UTHR Financial Facts

Total operating expenses: 146.48M
Research and development: 39.74M
See Full Income Statement

Commitments and contingencies:: 0
Marketable investments: 280.89M
See Full Balance Sheet

United Therapeutics Corp. (UTHR) Earnings

  |   Expand Research on UTHR
Next EPS Date N/A EPS Growth Rate +58.2%
Average EPS % Beat Rate +58.1% Revenue Growth Rate +19.6%
Average % Move 1-Wk after EPS +5.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/29/14 Q214 $2.57$1.75 +$0.82$322.8M$308.04M N/A Details
4/29/14 Q114 $1.77$1.65 +$0.12$289.4M$300.14M N/A Details
2/25/14 Q413 $2.88$1.51 +$1.37$289.02M$295.43M N/A Details
10/29/13 Q313 $2.98$1.59 +$1.39$302.2M$279.02M Details
7/25/13 Q213 $1.52$1.47 +$0.05$280.6M$250.17M Details
4/25/13 Q113 $1.24$1.47 -$0.23$245.1M$241.14M Details
2/14/13 Q412 N/A$1.24 N/A N/A$233.41M N/A N/A N/A
2/26/13 Q412 $1.65$1.25 +$0.40$243.82M$233.41M Details